Skip to main content
. 2015 Dec 22;10(12):e0145787. doi: 10.1371/journal.pone.0145787

Fig 1. Inclusion process and eligibility of study participants.

Fig 1

a) Diagnosed between January 1st 2002 and December 31st 2011, aged 0 to 18 years at diagnosis, treated at the Division of Pediatric Hematology/Oncology at the University Children’s Hospital Bern, Switzerland.